{"retracted":false,"update":{"timestamp":1423094400000,"doi":"10.1007/s12307-015-0165-y","type":"correction"},"doi":"10.1007/s12307-014-0161-7","journal":"Cancer Microenvironment","publisher":"Springer Nature","title":"Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan"}
